Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program

BACKGROUND: Cryptococcal antigen (CrAg) screening and treatment with preemptive fluconazole reduces the incidence of clinically evident cryptococcal meningitis in individuals living with advanced human immunodeficiency virus (HIV) disease. However, mortality remains higher in CrAg-positive than in C...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Wake, Rachel M, Govender, Nelesh P, Omar, Tanvier, Nel, Carolina, Mazanderani, Ahmad Haeri, Karat, Aaron S, Ismail, Nazir A, Tiemessen, Caroline T, Jarvis, Joseph N, Harrison, Thomas S
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Articles and Commentaries
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7346756/
https://ncbi.nlm.nih.gov/pubmed/31179488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz485
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires